Sidney Abbott v. Randon Bragdon, D.M.D.

163 F.3d 87, 8 Am. Disabilities Cas. (BNA) 1592, 1998 U.S. App. LEXIS 32708, 1998 WL 887125
CourtCourt of Appeals for the First Circuit
DecidedDecember 29, 1998
Docket96-1643
StatusPublished
Cited by13 cases

This text of 163 F.3d 87 (Sidney Abbott v. Randon Bragdon, D.M.D.) is published on Counsel Stack Legal Research, covering Court of Appeals for the First Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Sidney Abbott v. Randon Bragdon, D.M.D., 163 F.3d 87, 8 Am. Disabilities Cas. (BNA) 1592, 1998 U.S. App. LEXIS 32708, 1998 WL 887125 (1st Cir. 1998).

Opinion

*88 SELYA, Circuit Judge.

This case involves a claim of disability-based discrimination brought by an asymptomatic HIV-positive individual, Sidney Abbott, against Randon Bragdon, a dentist who refused to fill Ms. Abbott’s cavity in his office. The district court found Ms. Abbott’s case compelling and granted summary judgment in her favor. See Abbott v. Bragdon, 912 F.Supp. 580 (D.Me.1995) (Abbott I). We affirmed, albeit on somewhat different reasoning. See Abbott v. Bragdon, 107 F.3d 934 (1st Cir.1997) (Abbott II). The Supreme Court affirmed our decision in substantial part, but remanded with instructions that we reexamine several pieces of evidence. See Bragdon v. Abbott, — U.S.-, 118 S.Ct. 2196, 141 L.Ed.2d 540 (1998) (Abbott III). We ordered supplemental briefing, entertained a new round of oral argument, and now reaffirm the district court’s entry of summary judgment.

I

We limned the pertinent facts in our earlier opinion, see Abbott II, 107 F.3d at 937-38, and it would be pleonastic to rehearse them here. To lend context, it suffices to remind the reader that Ms. Abbott, who was infected with the Human Immunodeficiency Virus (HIV), went to Dr. Bragdon’s Bangor, Maine office for a dental appointment in September 1994; that she was then in the asymptomatic phase of the disease and so informed the dentist; and that, after Dr. Bragdon discovered a cavity, he refused to fill it in his office. Ms. Abbott sued, claiming violations of the Americans With Disabilities Act (the ADA), 42 U.S.C. § 12182 (1994), and the Maine Human Rights Act, 5 Me.Rev.Stat. Ann. tit. 5, § 4592 (West Supp.1998). 1

The earlier phases of this litigation established that asymptomatic HIV constitutes a disability under the ADA. See Abbott III, — U.S. at-, 118 S.Ct. at 2207 (aff'g Abbott II, 107 F.3d at 942). The sole remaining question is whether performance of the cavity-filling procedure posed a “direct threat” to others and thereby came within an exception to the ADA’s broad prohibition against discrimination. See Abbott II, 107 F.Bd at 943; see also 42 U.S.C. § 12182(b)(3) (stating the exception and defining a direct threat under the ADA as “a significant risk to the health or safety of others that cannot be eliminated by a modification of policies, practices, or procedures or by the provision of auxiliary aids or services”).

In the earlier appeal, our rejection of Dr. Bragdon’s direct threat defense relied in part on our reading of (i) the 1993 Dentistry Guidelines (the Guidelines) formulated by the Centers for Disease Control (CDC), and (ii) the Policy on AIDS, HIV Infection and the Practice of Dentistry (the Policy) propounded by the American Dental Association (the Association). See Abbott II, 107 F.3d at 945^16. Each of these documents indicated to us that the use of so-called “universal precautions” would render the risk of performing the cavity-filling procedure in a dental office insignificant. See id. We also noted the absence of a trialworthy showing by Dr. Bragdon as to any direct threat. See id. at 946-48. The Supreme Court remanded to permit a reevaluation of the evidence on this issue, and, in particular, a reexamination of the Guidelines and the Policy. See Abbott III, 118 S.Ct. at 2211-13. In doing so, the Court took pains to explain that its disposition did not debar us from again reaching the same result. See id. at 2213.

II

In compliance with the Court’s directive, we have reexamined the evidence to determine whether summary judgment was warranted. In order to reverse our course, we would have to find, contrary to our original intuition, either that (i) Ms. Abbott did not merit judgment as a matter of law even in the absence of disputed facts, or (ii) that Dr. Bragdon had submitted sufficient evidence to create a genuine issue of material fact as to his direct threat defense. In our reexamination, we apply conventional summary judgment jurisprudence, drawing all reasonable *89 factual inferences in favor of Dr. Bragdon (as the party opposing brevis disposition). See Abbott II, 107 F.3d at 988 (citing Smith v. F.W. Morse & Co., 76 F.3d 413, 428 (1st Cir.1996)). Despite the leniency of this approach, we do not indulge “conclusory allegations, improbable inferences, and unsupported speculation.” Medina-Muñoz v. R.J. Reynolds Tobacco Co., 896 F.2d 5, 8 (1st Cir.1990).

A. Ms. Abbott’s Evidence.

The Supreme Court raised questions regarding whether the Guidelines, which state that use of the universal precautions therein described “should reduce the risk of disease transmission in the dental environment,” necessarily imply that the reduction of risk would be to a level below that required to show direct threat. Abbott III, 118 S.Ct. at 2211 (quoting Guidelines). We have reconsidered this point.

The CDC did not write the 1993 Guidelines in a vacuum, but, rather, updated earlier versions issued in 1986 and 1987, respectively. The 1986 text calls the universal precautions “effective for preventing hepatitis B, acquired immunodeficiency syndrome, and other infectious diseases caused by blood-borne viruses.” The 1987 edition explains that use of the universal precautions eliminates the need for additional precautions that the CDC formerly had advocated for handling blood and other bodily fluids known or suspected to be infected with bloodborne pathogens. Neither the parties nor any of the amici have suggested that the 1993 rewrite was intended to retreat from these earlier risk assessments, and we find no support for such a position in the Guidelines’ text. Thus, we have again determined that the Guidelines are competent evidence that public health authorities considered treatment of the kind that Ms. Abbott required to be safe, if undertaken using universal precautions.

Second, the Court questioned the appropriate weight to accord the Policy, expressing concern that the Policy might be based in whole or in part on the Association’s view of dentists’ ethical obligations, rather than on a pure scientific assessment. See Abbott III, 118 S.Ct. at 2211-12. The supplemental briefing that we requested yielded a cornucopia of information regarding the process by which the Policy was assembled. We briefly recount the undisputed facts.

The Association formulates scientific and ethical policies by separate procedures, drawing on different member groups and different staff complements.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

ABADI v. TARGET CORPORATION
E.D. Pennsylvania, 2023
Doe v. Deer Mountain Day Camp, Inc.
682 F. Supp. 2d 324 (S.D. New York, 2010)
Burnett v. Puerto Rico Ports Authority
306 F. Supp. 2d 112 (D. Puerto Rico, 2004)
Powell v. City of Pittsfield
143 F. Supp. 2d 94 (D. Massachusetts, 2001)
John Doe v. County Of Centre
242 F.3d 437 (Third Circuit, 2001)
Doe v. County of Centre, PA
242 F.3d 437 (Third Circuit, 2001)
Charles E. Donahue v. Consolidated Rail Corporation
224 F.3d 226 (Third Circuit, 2000)
Onisheaa v. Hopper
171 F.3d 1289 (Eleventh Circuit, 1999)
Merchant v. Kring
50 F. Supp. 2d 433 (W.D. Pennsylvania, 1999)
Onishea v. Hopper
126 F.3d 1323 (Eleventh Circuit, 1997)

Cite This Page — Counsel Stack

Bluebook (online)
163 F.3d 87, 8 Am. Disabilities Cas. (BNA) 1592, 1998 U.S. App. LEXIS 32708, 1998 WL 887125, Counsel Stack Legal Research, https://law.counselstack.com/opinion/sidney-abbott-v-randon-bragdon-dmd-ca1-1998.